Skip to main content
OpenTrials
Completed

NCT Number: NCT02901561

Comparison Between 2 Doses of Misoprostol Before Intrauterine Device

The purpose of the investigators' study was to evaluate whether misoprostol will improve pain scores .

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

20 year–49 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 2 / Phase 3

Primary location

Ahmed Abbas

Assiut, Cairo Governorate, 002, Egypt

About this study

an intrauterine device can cause pain and discomfort in several ways: Use of the tenaculum to grasp the cervix and straighten the uterus for proper insertion; trans-cervical actions including measuring uterine depth, inserting the intrauterine device insertion tube, and removing the tube; and placement of the device in the uterus.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • • Women not taken analgesics or anxiolytics in the 24 hours prior insertion
  • Women who will accept to participate in the study

Exclusion criteria

  • Any contraindication to IUD placement

Treatment and study plan

misoprostol 200

Drug

misoprostol 400

Drug

Primary outcomes

  1. Mean pain score during intrauterine device insertion

    Time frame: 5 minutes

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Official study title

Comparison Between 2 Different Doses of Vaginal Misoprostol Before Intrauterine Device Insertion in Parous Women

Important dates

Study start
2016
Primary completion
2016
Study completion
2017
First posted
Sep 15, 2016
Registry last updated
Mar 14, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.